Chordoma: clinical characteristics, management and prognosis of a case series of 25 patients
Open Access
- 28 January 2010
- journal article
- Published by Springer Science and Business Media LLC in BMC Cancer
- Vol. 10 (1), 22
- https://doi.org/10.1186/1471-2407-10-22
Abstract
Adequate surgery still remains the only curative treatment of chordoma. Interesting clinical data on advanced disease with molecularly targeted therapies were reported.Keywords
This publication has 36 references indexed in Scilit:
- Response to imatinib plus sirolimus in advanced chordomaAnnals Of Oncology, 2009
- Cancer Statistics, 2007CA: A Cancer Journal for Clinicians, 2007
- Molecular and Biochemical Analyses of Platelet-Derived Growth Factor Receptor (PDGFR) B, PDGFRA, and KIT Receptors in ChordomasClinical Cancer Research, 2006
- Effectiveness of Cetuximab/Gefitinib in the Therapy of a Sacral ChordomaOncology Research and Treatment, 2006
- Patient Outcome at Long-term Follow-up after Aggressive Microsurgical Resection of Cranial Base ChordomasNeurosurgery, 2006
- Recurrent and metastatic clivus chordoma: systemic palliative therapy retards disease progressionAnti-Cancer Drugs, 2005
- Phase II Study of 9-Nitro-Camptothecin in Patients With Advanced Chordoma or Soft Tissue SarcomaJournal of Clinical Oncology, 2005
- Evaluation of a new concept for the management of skull base chordomas and chondrosarcomasJournal of Neurosurgery, 2005
- Chemotherapeutic Treatment of Malignant Chordoma in ChildrenJournal of Pediatric Hematology/Oncology, 1996
- Definitive radiation therapy for chordoma and chondrosarcoma of base of skull and cervical spineJournal of Neurosurgery, 1982